|
Augury Capital has developed an investment profile in privately held pharmaceutical, biotechnology, medical device and financial service informational technology companies with the following targeted characteristics:
• Experienced Management Teams
• Mid and Late-stage Medical Device companies (lower regulatory hurdle and quicker path to revenues) and medical device service companies
• Mid and Late-stage Service/Tool companies with unique technologies and/or services that solve fundamental issues (usually no regulatory hurdle with short-term revenue path)
• Late-stage Biopharmaceutical companies
• Mid and Late-stage financial services information technologies companies, particularly companies in the transaction processing sector
• Revenue generating companies with positive cash flow or expected cash flow within 12 months
• Companies seeking expansion capital
• Companies seeking operating and execution minded value-added investors
|
